Cyclobenzaprine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
A centrally acting skeletal muscle relaxant structurally related to tricyclic antidepressants, used for the short-term relief of muscle spasm associated with acute, painful musculoskeletal conditions. Cyclobenzaprine is most effective when used in conjunction with rest and physical therapy. It is not effective for spasticity from upper motor neuron disorders.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
A centrally acting skeletal muscle relaxant structurally related to tricyclic antidepressants, used for the short-term relief of muscle spasm associated with acute, painful musculoskeletal conditions. NutriStack rates the supporting evidence as strong. Common adult dosing is 5–10 mg three times daily; recommended for short-term use (2–3 weeks) (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: short-term relief of acute muscle spasm, improved sleep quality in patients with muscle pain, adjunct to rest and physical therapy. 10 sources indexed (2020–2026), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Acts primarily within the brainstem to reduce tonic somatic motor activity by influencing both gamma and alpha motor neurons. It reduces muscle hyperactivity without directly acting on skeletal muscle, the neuromuscular junction, or the spinal cord. The exact mechanism is not fully understood, but it may involve effects on descending serotonergic pathways in the brainstem reticular formation.
Dosing & protocol.
Can be taken with or without food; may cause significant drowsiness, take at bedtime if sedation is bothersome
Full safety detail.
Side effects
- Drowsiness (most common)
- Dry mouth
- Dizziness
- Fatigue
- Constipation
- Blurred vision
- Urinary retention
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
1- 1Short-term efficacy and safety of sublingual cyclobenzaprine for fibromyalgia: A systematic review and meta-analysisPMIDAl-Qudah AA, Al-Hanaktah M · Clinical rheumatology · 2026
Al-Qudah AA, Al-Hanaktah M. Short-term efficacy and safety of sublingual cyclobenzaprine for fibromyalgia: A systematic review and meta-analysis. Clinical rheumatology. 2026
Randomized controlled trials
3- 2Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprinePMIDLederman S, Arnold LM, Vaughn B et al. · Pain medicine (Malden, Mass.) · 2026
Lederman S, Arnold LM, Vaughn B et al.. Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine. Pain medicine (Malden, Mass.). 2026
- 3A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorderPMIDParmenter ME, Lederman S, Weathers FW et al. · Psychiatry research · 2024
Parmenter ME, Lederman S, Weathers FW et al.. A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder. Psychiatry research. 2024
- 4An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprinePMIDCaron J, Kaye R, Wessel T et al. · Journal of clinical pharmacy and therapeutics · 2020
Caron J, Kaye R, Wessel T et al.. An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine. Journal of clinical pharmacy and therapeutics. 2020
Reviews & position papers
1- 5Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting SystemPMIDTu J, Zhang C, Xie S et al. · Frontiers in medicine · 2025
Tu J, Zhang C, Xie S et al.. Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System. Frontiers in medicine. 2025
Reference material
5- 6Browning R et al. Cyclobenzaprine and back pain: a meta-analysis. Arch Intern Med. 2001.Source linkedPMID
- 7See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician. 2008.Source linkedPMID
- 8Elkalla MA et al. Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review. Clin Rheumatol. 2026.Source linkedPMID
- 9Lederman S, Arnold LM, Vaughn B et al.. Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis care & research. 2023Source linkedPMID
- 10Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis and rheumatism. 2004Source linkedPMID
Common questions.
Quick answers about Cyclobenzaprine, drawn from the data on this page.
What is Cyclobenzaprine?
A centrally acting skeletal muscle relaxant structurally related to tricyclic antidepressants, used for the short-term relief of muscle spasm associated with acute, painful musculoskeletal conditions. Cyclobenzaprine is most effective when used in conjunction with rest and physical therapy. It is not effective for spasticity from upper motor neuron disorders.
What is Cyclobenzaprine used for?
Commonly cited benefits of Cyclobenzaprine include: Short-term relief of acute muscle spasm; Improved sleep quality in patients with muscle pain; Adjunct to rest and physical therapy; Reduction of local muscle tenderness. NutriStack rates the overall evidence as strong.
What is a typical dose of Cyclobenzaprine?
A typical adult dose of Cyclobenzaprine is 5–10 mg three times daily; recommended for short-term use (2–3 weeks) (as prescribed by your physician). The commonly recommended form is Tablet or extended-release capsule. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Cyclobenzaprine?
Reported side effects include drowsiness (most common), dry mouth, dizziness, fatigue, constipation, blurred vision. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Cyclobenzaprine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Cyclobenzaprine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.